In this Friday’s COVID-19 Grand Rounds, Dr. Edward Mills of McMaster University and Dr. Jeffrey Glenn of Stanford University will present “Effect of Early Treatment With Single-Dose Pegylated Interferon Lambda Among Patients With COVID-19: Results From The TOGETHER Trial.”

The TOGETHER trial is a randomized adaptive platform trial investigating several treatments for COVID-19.

The Grand Rounds session will be held on Friday, July 29, at 1:00 pm eastern. Join the online meeting.

The NIH Pragmatic Trials Collaboratory Coordinating Center is using its popular Grand Rounds platform to share late-breaking research and promote resources in support of clinical researchers affected by the COVID-19 public health emergency. For previous COVID-19 Grand Rounds, and more news and resources related to the COVID-19 public health emergency, see the COVID-19 Resources page.